Kim, S Y <br/><br/>
The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  Nov 2012 
 - 1471-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.11.0602  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--pharmacology<br/>Bacterial Proteins--genetics<br/>Base Sequence<br/>DNA-Directed RNA Polymerases<br/>Drug Resistance, Bacterial<br/>Humans<br/>Limit of Detection<br/>Microbial Sensitivity Tests<br/>Microscopy--methods<br/>Molecular Sequence Data<br/>Mycobacterium tuberculosis--drug effects<br/>Nucleic Acid Amplification Techniques--methods<br/>Real-Time Polymerase Chain Reaction<br/>Republic of Korea--epidemiology<br/>Rifampin--pharmacology<br/>Sensitivity and Specificity<br/>Sputum--microbiology<br/>Time Factors<br/>Tuberculosis--diagnosis